Press releasePRNewswire
Biolase
BIOL · Other
$0.00−$0.0001 (−99.00%)TodayMarket closed ·
No price history for this range.
BIOL key statistics
- Market cap
- —
- Price-earnings ratio
- —
- Dividend yield
- 191.90%
- Average volume
- 112.93K
- Volume
- 4
- Open price
- $0.00
- High today
- $0.00
- Low today
- $0.00
- 52 Week high
- $104.00
- 52 Week low
- $1.07
Biolase (BIOL) at a glance
As of Oct 15, 2026, Biolase (BIOL) shares are priced at $0.00, giving the company a dividend yield of 191.90%.
Volume so far is 4 shares, below the average of 112.93K shares a day.
Over the past year Biolase has ranged from $1.07 to $104.00, and now sits -1% of the way up that range.
BIOL news
- Press releaseACCESSWIRE
BIOLASE Reports 2024 Second Quarter Results; Achieves 40% Gross Margin as Global Consumable Sales Strengthen
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.